Oral gel capsule formulation of 1,2,4-benzotriazine oxides
US5597582A · kind A · utility
4Cited by
1References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 12, 1995 |
| Grant date | Jan 28, 1997 |
| Priority date | — |
| Expiry date | Sep 12, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are anticancer tumor soft gelatin capsules comprising a 1,2,4-benzotriazine oxide and an oily excipient selected from the group consisting of soybean oil and fractionated coconut oil.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.